Deficiency of NOD1 Improves the b-Adrenergic Modulation of Ca2C Handling in a Mouse Model of Heart Failure. by Val Blasco, Almudena et al.
fphys-09-00702 June 13, 2018 Time: 16:44 # 1
ORIGINAL RESEARCH




Universidad de Sevilla, Spain
Reviewed by:
Marcelo Catalan,
Arturo Prat University, Chile
Jian Wu,







‡These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Membrane Physiology
and Membrane Biophysics,
a section of the journal
Frontiers in Physiology
Received: 01 March 2018
Accepted: 22 May 2018
Published: 14 June 2018
Citation:
Val-Blasco A, Navarro-García JA,
Tamayo M, Piedras MJ, Prieto P,
Delgado C, Ruiz-Hurtado G,
Rozas-Romero L, Gil-Fernández M,
Zaragoza C, Boscá L and
Fernández-Velasco M (2018)
Deficiency of NOD1 Improves
the β-Adrenergic Modulation of Ca2+
Handling in a Mouse Model of Heart
Failure. Front. Physiol. 9:702.
doi: 10.3389/fphys.2018.00702
Deficiency of NOD1 Improves the
β-Adrenergic Modulation of Ca2+
Handling in a Mouse Model of Heart
Failure
Almudena Val-Blasco1†, Jose A. Navarro-García2‡, Maria Tamayo3†‡, Maria J. Piedras4‡,
Patricia Prieto3†‡, Carmen Delgado3†, Gema Ruiz-Hurtado2, Laura Rozas-Romero1,
Marta Gil-Fernández1, Carlos Zaragoza5†, Lisardo Boscá3† and
María Fernández-Velasco1†*
1 Innate Immune Response Group, Instituto de Investigación Hospital Universitario La Paz, La Paz University Hospital,
Madrid, Spain, 2 Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research i+12, Hospital
Universitario 12 de Octubre, Madrid, Spain, 3 Departamento de Bioquímica, Facultad de Medicina, Instituto de
Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas, Madrid, Spain, 4 Department of
Anatomy, Faculty of Health Sciences, Francisco de Vitoria University (UFV), Pozuelo de Alarcón, Spain, 5 Unidad de
Investigación Cardiovascular, Universidad Francisco de Vitoria, Hospital Universitario Ramón y Cajal (IRYCIS), CIBERCV,
Madrid, Spain
Heart failure (HF) is a complex syndrome characterized by cardiac dysfunction, Ca2+
mishandling, and chronic activation of the innate immune system. Reduced cardiac
output in HF leads to compensatory mechanisms via activation of the adrenergic
nervous system. In turn, chronic adrenergic overstimulation induces pro-arrhythmic
events, increasing the rate of sudden death in failing patients. Nucleotide-binding
oligomerization domain-containing protein 1 (NOD1) is an innate immune modulator that
plays a key role in HF progression. NOD1 deficiency in mice prevents Ca2+ mishandling
in HF under basal conditions, but its role during β-adrenergic stimulation remains
unknown. Here, we evaluated whether NOD1 regulates the β-adrenergic modulation
of Ca2+ signaling in HF. Ca2+ dynamics were examined before and after isoproterenol
perfusion in cardiomyocytes isolated from healthy and from post-myocardial infarction
(PMI) wild-type (WT) and Nod1−/− mice. Isoproterenol administration induced similar
effects on intracellular [Ca2+]i transients, cell contraction, and sarcoplasmic reticulum
(SR)-Ca2+ load in healthy WT and Nod1−/− cells. However, compared with WT-PMI
cells, isoproterenol exposure induced a significant increase in the [Ca2+]i transients and
cell contraction parameters in Nod1−/−-PMI cells, which mainly due to an increase
in SR-Ca2+ load. NOD1 deficiency also prevented the increase in diastolic Ca2+
leak (Ca2+ waves) induced by isoproterenol in PMI cells. mRNA levels of β1 and
β2 adrenergic receptors were significantly higher in Nod1−/−-PMI hearts vs WT-PMI
hearts. Healthy cardiomyocytes pre-treated with the selective agonist of NOD1, iE-DAP,
and perfused with isoproterenol showed diminished [Ca2+]i transients amplitude, cell
contraction, and SR-Ca2+ load compared with vehicle-treated cells. iE-DAP-treated
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cells also presented increased diastolic Ca2+ leak under β-adrenergic stimulation. The
selectivity of iE-DAP on Ca2+ handling was validated by pre-treatment with the inactive
analog of NOD1, iE-Lys. Overall, our data establish that NOD1 deficiency improves the
β-adrenergic modulation of Ca2+ handling in failing hearts.
Keywords: β-adrenergic response, heart failure, NOD1, Ca2+ handling, innate immune system
INTRODUCTION
Heart failure (HF) is a complex clinical disorder characterized
by the inability of the heart to deliver blood and nutrients to
metabolic tissues. Chronic HF is a progressive disease, with
high morbidity and mortality, and poses a significant economic
burden on the healthcare system. Given its poor prognosis, the
identification of molecular pathways contributing to HF is a
major research goal.
Compensatory activation of the adrenergic nervous system
is a pathophysiological response to HF progression, which
functions to maintain cardiac homeostasis through activation
of neural hormones, mainly catecholamines (Gordan et al.,
2015). Accordingly, sympathetic hyperactivity is a hallmark of
HF, activating β-adrenergic receptors to increase heart rate and
cardiac contractility via excitation–contraction (EC) coupling, in
an attempt to counteract the decreased cardiac output. Chronic
exposure of the heart to elevated levels of catecholamines may,
however, ultimately lead to the desensitization of β-adrenergic
receptors, exacerbating the loss of cardiac function and increasing
the risk for triggered arrhythmias and sudden death (Feldman
et al., 2005; Brum et al., 2006; Venetucci et al., 2008).
There is a growing body of evidence suggesting a link
between the innate immune response and HF progression (Lin
and Knowlton, 2014; Mann, 2015). Whether the myocardial
inflammatory response impairs cardiac damage is a question of
broad significance. Recent studies indicate that some receptors
of the innate immune system, including nucleotide-binding
oligomerization domain-like receptors (NLRs), play significant
roles in the host response after cardiac damage (Bullón et al.,
2016; Monnerat et al., 2016; Val-Blasco et al., 2017a). Nucleotide-
binding oligomerization domain (NOD) receptors are NLR
family members that recognize conserved motifs of bacterial
peptidoglycans in many Gram-negative bacteria (Caruso et al.,
2014). Beyond their role as microbial pattern recognition
receptors, it has recently been described that NODs can also
be activated by non-infectious factors such as endoplasmic
reticulum stress (Keestra-Gounder et al., 2016). Ligand activation
of NOD receptors induces a conformational change in the
protein, leading to self-oligomerization and promoting the
recruitment of its adaptor, receptor-interacting protein 2 (RIP2),
which activates nuclear factor-κB and triggers the inflammatory
response (Park et al., 2007). NOD-containing protein 1 (NOD1)
is expressed in the heart, and is functional in resident fibroblasts
and cardiomyocytes (Fernández-Velasco et al., 2012; Delgado
et al., 2015). Several studies have demonstrated a role for
NOD1 in the progression of cardiovascular diseases, including
atherosclerosis and diabetic cardiomyopathy (Prieto et al.,
2014; Kanno et al., 2015; Val-Blasco et al., 2017b). We have
recently shown that NOD1 is upregulated in both mouse
and human failing myocardium, and its genetic deletion or
pharmacological blockade prevents cardiac dysfunction and
deleterious remodeling in failing hearts principally by preventing
the HF-related Ca2+ mishandling (Val-Blasco et al., 2017a).
Conversely, activation of NOD1 promotes a dysregulation of the
intracellular Ca2+ dynamics, similar to those observed in HF
(Delgado et al., 2015).
Ca2+ plays a key role in cardiac EC coupling. During
EC coupling, an action potential leads to a small increase in
intracellular Ca2+ via activated sarcolemmal L-type Ca channels
(ICaL), and this is amplified by a greater release of Ca2+ from
the sarcoplasmic reticulum (SR) by ryanodine receptors (RyR2),
increasing the intracellular Ca2+ concentration ([Ca2+]i) – a
process known as Ca2+-induced Ca2+ release. This elevation in
[Ca2+]i results in myofilament activation and cell contraction.
During relaxation, Ca2+ is removed from the cytosol primarily by
two mechanisms: Ca2+ re-uptake by the SR-ATPase (SERCA2a)
and Na+/Ca2+ exchanger activation.
Excitation–contraction coupling is modulated by the
sympathetic nervous system through activation of the
β-adrenergic receptor coupled to Gs-type G-proteins, promoting
an elevation in the intracellular concentration of cAMP (Bers,
2002). In turn, cAMP activates protein kinase A (PKA),
resulting in the phosphorylation of several EC coupling-Ca2+
transporters such as ICaL, RyR2, and phospholamban, among
others (Mayourian et al., 2018).
Several lines of evidence have established a direct relationship
between Ca2+ dysregulation and HF progression (Gómez
et al., 1997; Heinzel et al., 2011; Ruiz-Hurtado et al., 2015).
Depressed systolic Ca2+ release, the decline in the SR-Ca2+
load, and the increased Ca2+ diastolic leak seem to be key
players in HF progression, and these changes worsen under
chronic β-adrenergic activation. We recently showed that
NOD1 modulates intracellular Ca2+ handling in human and
experimental failing hearts (Val-Blasco et al., 2017a); however,
the role of NOD1 in the modulation of Ca2+ handling
under β-adrenergic stimulation has not been investigated. Using
a mouse HF model, we determined whether the deficiency




Male Nod1−/− mice on a C57BL/6J (6B; 129P2-Nod1tm1Nnz/J)
background were used in this study (Chamaillard et al., 2003). As
controls, we used wild-type (WT) C57BL/6J mice (The Jackson
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Laboratory, Bar Harbor, ME, United States). Experiments
involving mice were carried out in compliance with Spanish and
European guidelines (2010/63/EU) regarding animal policy and
welfare recommendations. The present study was performed in
male mice because they have been reported to be more prone
than female to develop cardiac injury and Ca2+ mishandling
after isoproterenol administration in experimental models of HF
(Cross et al., 2002).
Mice were anesthetized by intraperitoneal (i.p.) injection of
a mixture of ketamine (Imalgene R©, 70 mg/kg) and xylazine
(Rompun R©, 10 mg/kg). Unconscious mice were shaved in
the anterior region of the neck and the chest, intubated by
tracheostomy, and connected to a small animal ventilator
(MiniVent type 845, Harvard Apparatus) for artificial ventilation
at 150 strokes/minute and 230 µL stroke volume. A 2–3 mm
incision parallel to the lower costal edge was made and the
left pectoralis major muscle was dissociated until the ribs were
exposed. Left thoracotomy was performed between the third and
fourth ribs to visualize the anterior surface of the heart and
left lung. A 1-mm-thick piece of gelatin sponge (Spongostan R©),
slightly moistened with saline, was inserted through the hollow
thoracotomy to protect the lung. The ribs were separated
with an eyelid-retractor and a branch of the left coronary
artery was ligated with a blue polypropylene monofilament
surgical non-absorbable suture 6/0. The Spongostan R© sponge
was then removed and the chest was closed with braided
silk non-absorbable suture 4/0. Respiratory stimulation was
performed to return the heart to spontaneous breathing. For
postoperative analgesia, buprenorphine (Buprex R©, 0.05 mg/kg)
was applied subcutaneously. Mice were kept on a warm electric
blanket until spontaneous recovery. Sham-operated mice were
used as the control group and underwent the same procedure,
but without coronary ligation.
Myocyte Isolation
Adult male mice (2 months of age) were anesthetized with
sodium pentobarbital (100 mg/kg i.p.) and heparinized (4 UI/g
i.p.). Hearts were rapidly removed and cannulated via the
ascending aorta for Langendorff perfusion. Retrograde perfusion
was initiated with a free calcium Tyrode solution containing
0.2 mM EGTA over 2–3 min at room temperature, and
subsequently with Tyrode solution containing CaCl2 (0.1 mM)
and type II collagenase (1 mg/mL; Worthington Biochemical,
Lakewood, NY, United States). Successful digestion was assumed
when the flux rate increased and the heart color changed from
red to pallor. The heart was then taken off the apparatus,
and the ventricles were removed, minced into small pieces,
and mechanically dissociated in a thermostatic bath at 37◦C
in the enzymatic solution. The cardiomyocyte cell suspension
was filtered through a nylon mesh (250 µm) and centrifuged
at 300 rpm for 3 min. The cell pellet was suspended in
Tyrode solution containing CaCl2 (0.5 mM) and centrifuged
as before. Finally, the cells were suspended in Tyrode solution
containing CaCl2 (1 mM). The Tyrode solution contained
(in mM): 130 NaCl, 5.4 KCl, 0.5 MgCl2, 25 HEPES, 0.4
NaH2PO4, and 22 glucose, which was adjusted to pH 7.4 with
NaOH.
Confocal Microscopy
Local increases in intracellular Ca2+ concentration, [Ca2+]i
transients, and Ca2+ waves were analyzed in intact isolated
cardiomyocytes loaded with the fluorescent Ca2+ dye Fluo-
3AM (5 µmol/L, Invitrogen). [Ca2+]i transients were recorded
in cells electrically excited at 2 Hz by field stimulation using
two parallel platinum electrodes. Ca2+ waves were acquired in
quiescent myocytes. SR Ca2+ load was assessed by rapid caffeine
application (10 mM) in cells previously excited at 2 Hz.
Images were acquired by confocal microscopy (Meta Zeiss
LSM 710, 40× oil immersion objective with a 1.2 NA), by
scanning the cell with an argon laser every 1.54 ms. Fluo-3AM
was excited at 488 nm and emitted fluorescence was collected at
>505 nm. Data analysis was performed with homemade routines
using software written on the IDL platform (Research System
Inc., Boulder, CO, United States), designed by Dr. AM Gómez
(Inserm, UMR-S 1180). Images were corrected for background
fluorescence. The fluorescence values (F) were normalized by the
basal fluorescence (F0) to obtain the fluorescence ratio (F/F0).
Drugs and Treatments
Isolated cardiomyocytes were perfused with 10−8 M
isoproterenol (Sigma-Aldrich, Madrid, Spain) for 1–5 min
and intracellular Ca2+ dynamics were recorded. In some
experiments, cells were pretreated with the selective NOD1
agonist C12-iE-DAP (iE-DAP, InvivoGen, San Diego, CA,
United States), which has significant cell membrane permeability
and high potency (Fernández-Velasco et al., 2012; Delgado et al.,
2015; Val-Blasco et al., 2017a), or iE-Lys (Invivogen), an inactive
analog of NOD1. Nodinitib-1 (Cayman) was used as a selective
NOD1 inhibitor and mice were injected IP with 5 µmol/L
nodinitib-1 or vehicle (<0.01% DMSO) three times weekly for 6
weeks.
Real-Time PCR
Frozen heart tissue was pulverized to powder and then
homogenized in TRIZOL Reagent R© solution (Ambion) with a
Polytron system (MWR). RNA (250 ng) was reverse transcribed
to cDNA using theHigh-Capacity cDNAReverse Transcription Kit
(Applied Biosystems #4368813). This template cDNA was used
in the qPCR reaction with Power SYBR Green PCR Master mix
(Applied Biosystems #4367659) and specific primers in a 7900HT
Fast Real Time PCR system (Applied Biosystems). 18s-RNA was
used as a housekeeping gene. The primer sequences (5′-3′) for β1








Results are reported as mean ± SEM. Statistical analysis was
performed using two-way analysis of variance, paired (two-
sided) Student’s t test or χ2 test, as appropriate. All statistical
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analyses were performed with Origin 8.0 software (OriginLab,
Northampton, MA, United States). Significance was set at
P < 0.05.
RESULTS
Hypertrophy Development in Mice
Subjected to Myocardial Infarction
Compared with healthy WT mice, post-myocardial infarction
(PMI)-mice 6 weeks after surgery showed significantly increased
heart weight, heart weight/body weight ratio, and heart
weight/tibia length ratio, consistent with the development of
cardiac hypertrophy (Table 1). By contrast, Nod1−/−-PMI mice
showed similar heart weight, heart weight/body weight, and heart
weight/tibia length values to Nod1−/− mice (Table 1). These data
indicate that deficiency of NOD1 attenuates cardiac hypertrophy
in our PMI mouse model.
Deficiency of NOD1 Improves the
β-Adrenergic Modulation of Systolic
Ca2+ Release and Sarcoplasmic
Reticulum Ca2+ Load in PMI
Cardiomyocytes
We first analyzed whether deficiency of NOD1 determined
the β-adrenergic response to Ca2+ handling in healthy
myocytes. Isoproterenol perfusion induced a similar increase
in [Ca2+]i transients amplitude (Figure 1A), cell contraction
(Figure 1B), and SR-Ca2+ load (Figure 1C) in WT and Nod1−/−
cardiomyocytes.
Given that β-adrenergic regulation of Ca2+ dynamics
plays a key role in HF-related cardiac dysfunction, we next
questioned whether NOD1 deficiency impacted isoproterenol-
induced modulation of Ca2+ handling in cardiomyocytes
after PMI. Figure 1D shows representative line-scan Ca2+
fluorescence images obtained after electric field stimulation at
2 Hz in all groups. Under β-adrenergic stimulation, both WT-
PMI and Nod1−/−-PMI cardiomyocytes exhibited increased
[Ca2+]i transients (Figure 1E), augmented cell contraction
(Figure 1F), and faster time decay of [Ca2+]i transients
(Figure 1G), but all these changes were significantly greater
in Nod1−/−-PMI cells. These results reveal that, compared
with WT-PMI cells, Nod1−/−-PMI myocytes show a significant
improvement in Ca2+ mishandling, which was mostly due to
the increased amplitude of [Ca2+]i transients (Figures 1D,E) and
also higher cell contraction parameters (Figure 1F). In this line,
mean values of the amplitude of [Ca2+]i transients (F/F0) in
cardiomyctes obtained under isoproterenol administration were
5.31 ± 0.52 (n/N = 13/5) in WT, 5.18 ± 0.32 (n/N = 14/4)
in Nod1−/−, 4.18 ± 0.22 (n/N = 12/4) in WT-PMI, and
5.41 ± 0.21 (n/N = 13/4) in Nod1−/−-PMI (Figures 1A,E).
Thus, [Ca2+]i transients obtained in the Nod1−/−-PMI group
during isoproterenol perfusion were similar to those of equivalent
healthy WT and Nod1−/− cardiomyocytes. Consistent with this
finding, treatment of WT-PMI mice with the selective NOD1
inhibitor nodinitib-1 resulted in higher amplitude isoproterenol-
induced [Ca2+]i transients in isolated cardiomyocytes compared
with cells isolated from vehicle-treated mice (Supplementary
Figure S1).
Next, to question whether changes in [Ca2+]i transients
during β-adrenergic stimulation in PMI cardiomyocytes were
related to modifications in SR-Ca2+ load, we measured
caffeine-evoked [Ca2+]i transients in all groups. Figure 2A
shows examples of line-scan images of caffeine-evoked [Ca2+]i
transients obtained in each group. Mean values of the amplitude
of caffeine-evoked [Ca2+]i transients (F/F0) in cardiomyocytes
during isoproterenol exposure was 7.07± 0.69 (n/N = 9/3) in WT,
7.34 ± 0.93 (n/N = 10/4) in Nod1−/− (Figure 1C), 5.77 ± 0.46
(n/N = 13/4) in WT-PMI, and 7.40 ± 0.50 (n/N = 12/4) in
Nod1−/−-PMI (Figure 2B). Thus, the amplitude of [Ca2+]i
transients triggered by caffeine was significantly higher in
Nod1−/−-PMI mice than in WT-PMI mice, both in the absence
or the presence of isoproterenol (Figure 2B). Additionally, the
high values of SR-Ca2+ load in the Nod1−/−-PMI group treated
with isoproterenol were similar to those found in healthy WT and
Nod1−/− cells treated with isoproterenol.
Taken together, β-adrenergic stimulation induced better
systolic Ca2+ release and cell contractility in Nod1−/−-PMI
cells than in WT-PMI cells. These effects correlated with the
significant increase in the SR-Ca2+ load induced by isoproterenol
in Nod1−/−-PMI cells.
Deficiency of NOD1 Prevents the
Increased Diastolic Ca2+ Release
Induced by β-Adrenergic Stimulation in
PMI Cardiomyocytes
Since SR-Ca2+ load impairment is closely related to changes in
diastolic Ca2+ release, we analyzed spontaneous Ca2+ waves in
quiescent cells.
TABLE 1 | Cardiac properties of wild-type and Nod1-deficent mice.
WT (N = 5) Nod1−/− (N = 5) WT-PMI (N = 4) Nod1−/−-PMI (N = 4)
HW (mg) 187.20 ± 3.72 173.60 ± 4.79 272.00 ± 10.70∗∗∗ 193.5 ± 13.35&&
BW (g) 29.71 ± 1.37 29.95 ± 1.14 31.47 ± 0.54 30.03 ± 1.14
TL (mm) 21.90 ± 0.40 21.50 ± 0.31 21.25 ± 0.47 21.50 ± 0.28
HW/TL (mg/mm) 8.56 ± 0.25 8.08 ± 0.27 12.81 ± 0.53∗∗∗ 9.01 ± 0.66&&
HW/BW (mg/g) 6.35 ± 0.32 5.82 ± 0.22 8.65 ± 0.37∗∗ 6.36 ± 0.26&&
HW, heart weight; BW, body weight; TL, tibia length. ∗∗P < 0.01, ∗∗∗P < 0.001 vs WT and &&P < 0.01 vs WT-PMI.
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FIGURE 1 | Deficiency of NOD1 improves the modulation of systolic Ca2+ handling and SR-Ca2+ load by β-adrenergic stimulation in cardiomyocytes from failing
mice. (A–C) Mean values of amplitude of [Ca2+]i transients (F/F0, A), cell contractions (CC, %, B), and caffeine-evoked [Ca2+]i transients amplitude (SR-Ca2+ load,
F/F0, C) in WT (n = 13 cells/5 mice) and NOD1−/− cardiomyocytes (n = 14 cells/4 mice) with and without 10−8 M isoproterenol (Iso). (D) Representative line-scan
confocal images of [Ca2+]i transients obtained from WT-PMI and NOD1−/−-PMI cardiomyocytes with and without Iso perfusion. (E,F) Mean values of peak
fluorescence [Ca2+]i transients (F/F0, E), cell contraction (CC, %, F), and decay time of [Ca2+]i transients (tau, ms, G) in WT-PMI (n = 12 cells/4 mice) and
NOD1−/−-PMI (n = 13 cells/4 mice) cardiomyocytes with and without Iso. Histograms represent the mean ± SEM: $$P < 0.01, $$$P < 0.001 vs WT; +P < 0.05 vs
NOD1−/−, ++P < 0.01 vs NOD1−/−, +++P < 0.001 vs NOD1−/−; ∗P < 0.05 vs WT-PMI; &P < 0.05, &&P < 0.01, &&&P < 0.001 vs NOD1−/−-PMI; and
#P < 0.05, ###P < 0.001 vs WT-PMI treated with Iso.
Figure 3A shows a representative line-scan image
of a Ca2+ wave recording from a WT-PMI myocyte.
Ca2+ wave occurrence analysis (Figure 3B) revealed no
statistically significant changes between WT-PMI (14.60%)
and Nod1−/−-PMI (10.50%) cells under basal conditions.
By contrast, both groups showed a significant elevation in
the Ca2+ wave rate after isoproterenol perfusion, but this
was significantly higher in WT-PMI cardiomyocytes perfused
with isoproterenol (Figure 3). Accordingly, the percentage
of cells with Ca2+ waves during isoproterenol exposure was
34.07% in WT-PMI cells and 15.65% in Nod1−/−-PMI cells
(P < 0.01).
These results indicate that deficiency of NOD1 prevents
the increase of Ca2+ diastolic leak induced by β-adrenergic
stimulation in PMI cardiomyocytes, thus providing an
explanation for the improvement in the SR-Ca2+ load and
the resulting better systolic Ca2+ release in Nod1−/−-PMI cells
under isoproterenol administration.
mRNA Levels of the β1 and β2
Adrenergic Receptors Are Elevated in
Nod1−/−-PMI Hearts
Analysis of the mRNA levels of β1 and β2 adrenergic receptors
in hearts from WT-PMI and Nod1−/−-PMI mice revealed
significantly increased expression of both receptors in Nod1−/−-
PMI hearts (Figures 4A,B). These increased β1 and β2 adrenergic
receptor levels can explain at least in part the improvement in
Ca2+ regulation observed in the Nod1−/−-PMI group under
isoproterenol administration.
Selective Activation of NOD1
Compromises the β-Adrenergic
Regulation of Ca2+ Handling in
Wild-Type Cardiomyocytes
We next addressed whether the selective activation of NOD1
impairs the β-adrenergic regulation of Ca2+ handling in
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FIGURE 2 | Deficiency of NOD1 increases the β-adrenergic response on
SR-Ca2+ load in cardiomyocytes from failing mice. (A) Representative
line-scan confocal images of caffeine-evoked [Ca2+]i transients obtained from
WT-PMI and NOD1−/−-PMI cardiomyocytes with and without Iso perfusion.
(B) Mean values of caffeine-evoked [Ca2+]i transients amplitude (SR-Ca2+
load, F/F0) in WT-PMI (n = 23 cells/4 mice), NOD1−/−-PMI (n = 19 cells/4
mice), WT-PMI (n = 13 cells/4 mice), and NOD1−/−-PMI (n = 12 cells/4 mice)
cardiomyocytes treated with Iso. Histograms represent the mean ± SEM:
∗∗P < 0.01, ∗∗∗P < 0.001 vs WT-PMI; &&&P < 0.001 vs NOD1−/−-PMI; and
#P < 0.05 vs WT-PMI cardiomyocytes treated with Iso.
FIGURE 3 | Deficiency of NOD1 prevents the increase in diastolic Ca2+
release induced by isoproterenol in cardiomyocytes from failing mice. (A) A
representative line-scan image of a Ca2+ wave recording from a WT-PMI
myocyte. (B) The mean data for Ca2+ wave occurrence from WT-PMI (n = 9
cells/3 mice) and NOD1−/−-PMI (n = 7 cells/3 mice) cardiomyocytes with and
without Iso. Histograms represent the mean ± SEM: ∗P < 0.05,
∗∗∗P < 0.001, vs WT-PMI; &P < 0.05, &&&P < 0.001 vs NOD1−/−-PMI; and
##P < 0.05 vs WT-PMI cardiomyocytes treated with Iso.
FIGURE 4 | Hearts from Nod1−/−-PMI mice have elevated mRNA levels of
β1 and β2 adrenergic receptors. Histograms illustrate mRNA levels of β1 (A)
and β2 (B) adrenergic receptors normalized to 18s RNA levels obtained in
WT-PMI (N = 6) and Nod1−/−-PMI hearts (N = 6). Values are expressed in
arbitrary units. ∗∗∗P < 0.001 vs WT-PMI.
healthy cardiomyocytes. To do this, we pretreated WT
cardiomyocytes for 1 h with the NOD1 ligand C12-iE-DAP
(iEDAP; 20 µg/mL) and then we examined intracellular Ca2+
dynamics in the absence or presence of isoproterenol perfusion.
Under isoproterenol stimulation, iE-DAP-treated cells showed
reduced amplitude of [Ca2+]i transients (Figures 5A,B),
cell contraction (Figure 5C), and SR-Ca2+ load (Figure 5D)
compared with vehicle-treated cardiomyocytes. Treatment of
cells with the inactive analog of IE-DAP, iE-Lys (20 µg/mL),
resulted in a similar isoproterenol response for Ca2+ handling
to vehicle-treated cells, demonstrating the selective effect of
iE-DAP on Ca2+ handling under β-adrenergic stimulation
(Figures 5A–D).
Finally, we investigated whether the selective activation
of NOD1 impairs diastolic Ca2+ release under β-adrenergic
stimulation. As shown in Figure 5E, isoproterenol perfusion
promoted a significant increase in Ca2+ waves in WT
cells pretreated with iE-DAP as compared with vehicle- or
iE-Lys-treated cells. Importantly, the percentage of Ca2+
waves in cells that were pretreated with iE-DAP and under
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FIGURE 5 | Effect of Isoproterenol on [Ca2+]i transients, SR-Ca2+ load, and diastolic Ca2+ release in wild-type cardiomyocytes treated with C12-iE-DAP.
(A) Representative [Ca2+]i transients recorded in cardiomyocytes treated with vehicle (left), C12-iEDAP (20 µg/mL IEDAP, middle), and iE-LYS (20 µg/mL IELYS,
right), with (red) or without (black) Iso. Mean values of (B) peak fluorescence [Ca2+]i transients, (C) cell contraction, (D) caffeine-evoked [Ca2+]i transients amplitude
(SR-Ca2+ load), and (E) Ca2+ wave occurrence in cardiomyocytes treated with vehicle (veh; n = 15 cells/7 mice), C12-iE-DAP (IEDAP n = 16 cells/6 mice), or with
iE-Lys (IELYS, n = 14 cells/5 mice) in the absence or the presence of Iso. Histograms represent the mean ± SEM: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs veh;
##P < 0.01, ###P < 0.001 vs IEDAP; &P < 0.05, &&&P < 0.001 vs IELYS; $P < 0.05, $$P < 0.01, $$$P < 0.001 vs veh plus Iso; and ¬¬P < 0.01, ¬¬¬P < 0.001 vs
IEDAP
plus Iso.
isoproterenol perfusion was very similar to that found in
WT-PMI cardiomyocytes under the same conditions (34.07% in
WT-PMI cells and 29.20% in cells treated with iE-DAP; compare
Figures 3C, 5E). Supporting these data, iE-DAP administration
failed to increase the percentage of Ca2+-wave-positive Nod1−/−
cardiomyocytes (data not shown).
Overall, these results indicate that NOD1 activation limits the
β-adrenergic regulation of Ca2+ handling due to impairment
of systolic Ca2+ release ([Ca2+]i transients) and SR-Ca2+ load,
which are highly conditioned by the increased diastolic Ca2+
leak.
DISCUSSION
Over the last decade, a large number of studies have shown that
compensatory upregulation of the adrenergic nervous system
response is a key factor in disease progression in chronic failing
hearts. During the early stages of HF, there is a steady activation
of the sympathetic nervous system to maintain cardiac output
(Lymperopoulos, 2013), whereas in later stages, continuous
adrenergic stimulation triggers negative feedback regulation of
β-receptor activity, causing a downregulation in the number
of receptors and also functional impairment, a process termed
Frontiers in Physiology | www.frontiersin.org 7 June 2018 | Volume 9 | Article 702
fphys-09-00702 June 13, 2018 Time: 16:44 # 8
Val-Blasco et al. NOD1 and Failing β-Adrenergic Calcium
receptor desensitization (Böhm et al., 1990; Madamanchi, 2007),
ultimately contributing to toxicity and worsening of cardiac
outcomes.
Some innate immune mediators, such as NLRs, play an
important role in the host response to cardiac damage. Among
them, NOD1 is expressed and functional in the heart (Fernández-
Velasco et al., 2012; Delgado et al., 2015) and is upregulated in
failing hearts both in a mouse HF model and in failing human
myocardium (Val-Blasco et al., 2017a). Genetic deletion of NOD1
prevents HF-related cardiac dysfunction through modulation of
EC coupling, chiefly by improving systolic Ca2+ release and by
maintaining Ca2+ SR load, which are both compromised in HF
(Val-Blasco et al., 2017a).
Our present results show that deficiency of NOD1 does
not affect the regulation of Ca2+ handling by β-adrenergic
stimulation under physiological conditions, as systolic Ca2+
release and SR-Ca2+ load were similar between WT and
Nod1−/− cardiomyocytes. In the failing heart, however,
deficiency of NOD1 prevents the depression of [Ca2+]i
transients and cell contractility due to maintained SR Ca2+
load. Accordingly, during β-adrenergic stimulation, deficiency
of NOD1 leads to a significant improvement in systolic Ca2+
release, cell contraction parameters, and SR Ca2+ load in
PMI cardiomyocytes, with levels mirroring those found in
isoproterenol-stimulated WT and healthy Nod1−/−cells. These
results are interesting given that the decreased β-adrenergic
function in HF plays a key role in the compromised cardiac
contraction.
Several groups have shown that other pro-inflammatory
mediators including TNFα, CXR4 or IL-1β impair the
β-adrenergic response and reduce cardiac contractility (Gulick
et al., 1989; Finkel et al., 1992; Schulz et al., 1995; Murray and
Freeman, 1996; Pyo et al., 2006), and short-term treatment
of rat cardiomyocytes with the pro-inflammatory cytokines
IL-1α and TNFα blocks isoproterenol-induced increases in
cell contractility (Bick et al., 1997). These findings are in
agreement with an early report implicating IL-1β in uncoupling
β-adrenergic responses in cardiomyocytes (Gulick et al., 1989).
Consistent with these data, our study shows that a selective
NOD1 agonist induces a minor but significant effect on cell
contractility in isoproterenol-treated cardiomyocytes. NOD1
activation also reduced the β-adrenergic modulation of systolic
Ca2+ release due to reduced SR-Ca2+ load, and by increasing
the diastolic Ca2+ leak. These results can be explained by
the fact that NOD1 activation in cardiomyocytes induces the
over-phosphorylation of RyR2, promoting the open state of the
receptor and inducing Ca2+ release from the SR to the cytoplasm,
increasing the diastolic Ca2+ leak (waves), and compromising
the SR-Ca2+ load (Delgado et al., 2015; Val-Blasco et al.,
2017a).
In many cases, increased diastolic Ca2+ release is the cause
of depressed SR-Ca2+ load in HF. Our data show that during
β-adrenergic stimulation, diastolic Ca2+ release is significantly
increased in failing WT cells, whereas deficiency of NOD1
prevents the increase in the HF-related diastolic Ca2+ waves.
These data go some way to explain the improvement in the
SR-Ca2+ load and the resulting improved systolic Ca2+ release
and cell contractility in Nod1−/−-PMI cells under isoproterenol
stimulation.
Nod1−/−-PMI hearts showed physiological levels of phospho-
RyR2 (Val-Blasco et al., 2017a), thus contributing to block
Ca2+ diastolic leak in Nod1−/−-PMI cardiomyocytes. Aberrant
diastolic Ca2+ leak in many cases such as HF leads to
arrhythmogenesis and cardiac dysfunction (Reiken et al., 2003;
Ai et al., 2005; van Oort et al., 2010; Marks, 2013; Terentyev
et al., 2014). RyR-derived Ca2+ leak can cause arrhythmias by
Ca2+ waves that trigger delays after depolarizations (Lehnart
et al., 2006). Pro-arrhythmogenic events are common in failing
patients, particularly under β-adrenergic stimulation, and around
30–50% of these individuals die from sudden cardiac death,
mostly associated with ventricular arrhythmias. Our data suggest
that blocking NOD1 can be a new tool to prevent ventricular
arrhythmias and cardiac dysfunction resulting from Ca2+
mishandling in HF.
In line with our results, elevated levels of the inflammatory
cytokines TNFα and IL-1β have been reported in both tissue
and plasma from HF patients with arrhythmias (Levine et al.,
1990; Testa et al., 1996; Aukrust et al., 2004). Moreover, other
inflammatory mediators such as Toll-like receptors (TLRs) have
been implicated in the generation of ventricular and atrial
arrhythmias (Katoh et al., 2014; Monnerat-Cahli et al., 2014;
Gurses et al., 2016). Importantly, TLRs seem to play a role in the
regulation of the β-adrenergic response. Accordingly, Kizaki et al.
(2008) demonstrated that TLR4 stimulation induces a down-
regulation of β2 receptors in macrophages (Wang et al., 2009). In
this regard, our results demonstrate that hearts from Nod1−/−-
PMI mice have higher mRNA levels of β1 and β2 adrenergic
receptors than WT-PMI hearts, suggesting a possible mechanism
for the larger systolic Ca2+ release and SR Ca2+ reuptake in
by Nod1−/−-PMI mice. β-adrenergic receptors are activated
through heterotrimeric G proteins and subsequent activation
of the adenylyl cyclase, which modulates the activity of several
proteins essential for EC Ca2+ coupling, such as ICaL, RyR2, and
phospholamban (Mayourian et al., 2018). Therefore, the elevated
β-adrenergic receptor levels in Nod1−/−-PMI cells may increase
the efficiency of cardiac EC coupling through the augmented
function of ICaL, RyR, and SERCA, improving both systolic Ca2+
release and SR Ca2+ loading in failing hearts.
One of the most common treatments to manage β-adrenergic
impairment in HF patients is the use of β-blockers. It
has been demonstrated that β-blocker treatment reduces the
detrimental effects of catecholamine stimulation, such as
toxicity, pathological elevated heart rate, and adverse remodeling
and arrhythmia development in failing patients. Improving
β-adrenergic regulation of Ca2+ handling by blocking NOD1 can
be a new tool to improve the cardiac function in failing hearts.
CONCLUSION
Our study demonstrates that deficiency of NOD1 improves
the β-adrenergic modulation of Ca2+ handling in isolated
cells from failing mice. Therefore, NOD1 emerges as a
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new potential target in the treatment of cardiac dysfunction and
ventricular arrhythmias associated with HF.
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